BioSpace News Archive

Q BioMed Inc., a commercial stage biotech company, announced that it has hired WSI PBG, LLC, a Michigan based firm specializing in creating access for and selling pharmaceuticals, medical diagnostics and durable medical equipment in the Veterans Administration, Military Health System and Indian Healthcare System.

Results to be presented at the American Society of Clinical Oncology (ASCO) virtual scientific program on June 7

DNA Script, a leading pioneer in enabling enzymatic DNA synthesis on demand, announced the third and final phase of its evaluation program for the SYNTAX System, the world’s first benchtop printer powered by Enzymatic DNA Synthesis technology.

The webinars highlight ways employers, payers, and government programs can improve healthcare affordability and outcomes for underserved populations.

Incyte announced that it will present at the following investor conferences during the month of June

Medeor Therapeutics, Inc. , a clinical-stage company dedicated to the development and commercialization of immunotherapies for transplantation, today announced that interim results of ts Phase 3 study clinical trial for MDR-101 cell therapy

Sparta Group has signed a Memorandum of Understanding, with CASPR Group of Addison TX to formalize an exclusive distribution and development agreement, for the North American transportation sector, between Sparta’s TruckSuite™ division and CASPR™, as well as to develop a non-exclusive agreement between Sparta Health Group and CASPR™.

Intensity Therapeutics Announces Two Abstracts to Be Presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for infectious diseases, vaccines, rare diseases, and oncology, is now enrolling UK volunteers into a pivotal Phase III COVID-19 vaccine study.

Predictive Oncology (NASDAQ: POAI), an artificial intelligence driven oncology and drug discovery company, announced today that its wholly owned subsidiary, TumorGenesis (TumorGenesis.net), has partnered a deal with the Swedish firm Cellevate AB (Cellevate.com).